Product Information
ATOVAQUONE-PROGUANIL 250-100 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.6129 per EA under NDC 00378416201. Its NADAC has been published 624 times since Jul 16, 2014.
The Low Outlier badge above means this manufacturer's average price in the atovaquone and proguanil hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250; 100 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378416201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOVAQUONE; PROGUANIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202362On Market Since
5/28/2014
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE-PROGUANIL 250-100 MG TABLET has been published 624 times since Jul 16, 2014, and over the history we have for it it has declined 69.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6129 per EA |
|---|---|
| All-time high | $5.4053 (Jun 10, 2015) |
| All-time low | $1.2534 (Nov 20, 2024) |
| 52-week high | $1.8095 |
| 52-week low | $1.4983 |
| Median price | $2.6656 |
| Average price | $3.0008 |
| Largest weekly change | +67.1% (Feb 22, 2023) |
| Weeks tracked | 624 |
| Tracking since | Jul 16, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATOVAQUONE-PROGUANIL 250-100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE-PROGUANIL 250-100 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.6129 per EA (NDC 00378416201), effective Jun 24, 2026.
How has the price of ATOVAQUONE-PROGUANIL 250-100 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE-PROGUANIL 250-100 MG TABLET has declined 69.6%. It has been tracked across 624 weekly CMS publications since Jul 16, 2014.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE-PROGUANIL 250-100 MG TABLET?
Since Jul 16, 2014, the NADAC for ATOVAQUONE-PROGUANIL 250-100 MG TABLET has ranged from a low of $1.2534 (Nov 20, 2024) to a high of $5.4053 (Jun 10, 2015), with a median of $2.6656 per EA.
Are there cheaper alternatives to ATOVAQUONE-PROGUANIL 250-100 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ATOVAQUONE-PROGUANIL 250-100 MG TABLET, but none are currently priced below it.
Who manufactures ATOVAQUONE-PROGUANIL 250-100 MG TABLET?
ATOVAQUONE-PROGUANIL 250-100 MG TABLET (NDC 00378416201) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification